Page last updated: 2024-10-27

flecainide and Benign Neoplasms

flecainide has been researched along with Benign Neoplasms in 2 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research Excerpts

ExcerptRelevanceReference
"In a general population of patients with a working diagnosis of neuropathic pain, whether if flecainide produces enough of an improvement in pain to warrant further clinical study is determined."9.12Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. ( Cella, D; Cleary, JF; Cleeland, C; Eappen, S; Moots, P; Regevik, N; Taylor, SG; von Gunten, CF, 2007)
"In a general population of patients with a working diagnosis of neuropathic pain, whether if flecainide produces enough of an improvement in pain to warrant further clinical study is determined."5.12Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. ( Cella, D; Cleary, JF; Cleeland, C; Eappen, S; Moots, P; Regevik, N; Taylor, SG; von Gunten, CF, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
von Gunten, CF1
Eappen, S1
Cleary, JF1
Taylor, SG1
Moots, P1
Regevik, N1
Cleeland, C1
Cella, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Flecainide for the Treatment of Chronic Neuropathic Pain: A Phase II Trial[NCT00002996]Phase 220 participants (Anticipated)Interventional1998-05-04Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for flecainide and Benign Neoplasms

ArticleYear
Flecainide for the treatment of chronic neuropathic pain: a Phase II trial.
    Palliative medicine, 2007, Volume: 21, Issue:8

    Topics: Adult; Aged; Analgesics; Female; Flecainide; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Pain;

2007
Flecainide in cancer nerve pain.
    Lancet (London, England), 1991, Jun-01, Volume: 337, Issue:8753

    Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Female; Flecainide; Humans; Male

1991